Recently, Li et al. reported that a triagonist of glucagon-like peptide-1(GLP-1)/gastric inhibitory polypeptide/glucagon receptors produced neurotrophic and neuroprotective action by reducing cell cytotoxicity and glutamate excitotoxicity by elevating cyclic adenosine monophosphate (cAMP) levels in human neuroblastoma cell-line SH-SY5Y [11]. Here, GCG is linked to neuroblastoma.